Up next

Autoplay

Immunotherapy for Head and Neck Cancer Treatment

1 Views • 07/02/23
Share
Embed
administrator
administrator
Subscribers
0

Head and neck cancer and skull base surgeon Nyall London discusses immunotherapy clinical trials that have contributed to FDA approval for nivolumab and pembrolizumab for recurrent head and neck squamous cell carcinoma. https://hopkinsmedicine.org/oto #HeadandNeckCancerTreatment #JohnsHopkins

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay